Abstract:Background/Objective: Familial Adenomatous Polyposis (FAP) is a condition characterized by values exceeding hundreds of colorectal adenomatous polyps. FAP has a prevalence of 1 in 8,300 people, demonstrating an autosomal dominant inheritance pattern. This condition follows a pathogenic variation of the Adenomatous Polyposis Coli (APC) gene, located on chromosome 5q21-22. These mutations are heavily correlated with the incidence of colorectal carcinoma, requiring prophylactic colectomy. The management and treatment of FAP requires routine surveillance to reduce gastrointestinal polyp burden. The objective for this study is to characterize the current patient population at Riley with polyposis syndromes and assess clinical surveillance in patients diagnosed with FAP. Methods: Historical data from 2020-2022 GI clinical visits were reviewed using the diagnostic codes Family history of colonic polyps, Benign neoplasm of colon unspecified, and Other phakomatoses not elsewhere classified. These criteria identified 93 patients of which 64 patients were diagnosed with a hereditary polyposis syndrome for inclusion within the registry. Of the 64 patients, 42 had a diagnosis of FAP. Clinical data reviewed included the patient’s age of diagnosis, completion of genetic testing and follow-up, surgical treatment, routine endoscopic surveillance, and modes of imaging. Results: Results indicated a median age of diagnosis of 10 years, lower than previously reported national averages of 13.5-17 years. Evaluation of routine follow-up indicated a rate of endoscopy at 0.822 scopes per year and demonstrated that abdominal CT scans as well as abdominal X-rays were the most common supplemental modes of imaging. Conclusion/ Future Directions: The data from this registry will help direct care of patients with FAP, ensuring they receive treatment in accordance with national guidelines for routine surveillance and prophylactic colectomy. Moving forward, the intention is to expand the registry's date range to incorporate more patients and elaborate further on endoscopic findings for the specific subtypes of FAP.

Familial Adenomatous Polyposis or APC-Associated Polyposis

The advances of familial adenomatous polyposis

Attenuated familial adenomatous polyposis (AFAP) in a patient associated with a novel mutation in APC

Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature

Comparison of two cases of Familial Adenomatous Polyposis with the same APC genotype and different phenotypes

A novel pathogenic single nucleotide germline deletion in APC gene in a four generation Chinese family with familial adenomatous polyposis

Genetic Causes of Familial Adenomatous Polyposis (FAP), Risk Factors and Clinical Outcomes

Familial Adenomatous Polyposis with Atypical Clinical Morphology and Genetic Variants

Gastric polyposis and desmoid tumours as a new familial adenomatous polyposis clinical variant associated with APC mutation at the extreme 3′-end

An Unsuspecting Case of Familial Adenomatous Polyposis (FAP)

Guidelines for the clinical management of familial adenomatous polyposis (FAP)

A novel APC mutation identified in a large Chinese family with familial adenomatous polyposis and a brief literature review

A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Chinese family with familial adenomatous coli

Genetic characteristics and extracolonic phenotypic manifestations in patients with familiar adenomatous polyposis

[A novel APC gene germline mutation in a familial adenomatous polyposis pedigree].

A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis

APC transcription studies and molecular diagnosis of familial adenomatous polyposis

Integrated genotype-phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas

Familial Adenomatous Polyposis within the Pediatric Hereditary Polyposis Registry

Adenomatous Polyposis Syndromes: Familial Adenomatous Polyposis and MutYH-Associated Polyposis

T cell migration and effector function differences in familial adenomatous polyposis patients with APC gene mutations